Cite
HARVARD Citation
Bonifati, C. et al. (2020). Effectiveness of etanercept biosimilar SB4 in maintaining low disease activity in patients with psoriatic arthritis switched from etanercept originator: an open-label one year study. Journal of dermatological treatment. pp. 687-691. [Online].